FDA Inspection 1115356 — Institute for Reproductive Medicine and Science at Saint Barnabas, P.A.
The FDA completed an inspection of Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. on January 15, 2020 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 15, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Livingston, NJ (United States)